ExploreWatchlistsPricing
  1. JP-listed companies
  2. Eisai Co., Ltd.
  3. Financials
  4. Net income

Eisai Co., Ltd. (4523)

Market cap
¥1.43T
P/E ratio
33.2x
Eisai develops, manufactures and sells prescription drugs and over-the-counter medicines globally across Japan, North America, China, Europe and Asia.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Mar 31, 202546,432+9.49%
Mar 31, 202442,406-23.50%
Mar 31, 202355,432+15.59%
Mar 31, 202247,954+13.85%
Mar 31, 202142,119-65.41%
Mar 31, 2020121,767+92.10%
Mar 31, 201963,386+22.26%
Mar 31, 201851,845+31.73%
Mar 31, 201739,358-28.35%
Mar 31, 201654,933+27.00%
Mar 31, 201543,254+13.08%
Mar 31, 201438,251-25.98%
Mar 31, 201351,674+21.95%
Mar 31, 201242,373

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat